These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17394441)

  • 61. [Intracoronary autologous bone marrow-derived stem cell transplantation in patients with ischemic cardiomyopathy: results of 18-month follow-up].
    Tayyareci Y; Umman B; Sezer M; Beşişik S; Sanli Y; Mudun A; Gürses N; Nişanci Y
    Turk Kardiyol Dern Ars; 2008 Dec; 36(8):519-29. PubMed ID: 19223717
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Retrograde intravenous perfusion--a therapeutic method in trophic defects of the lower extremities. Experience in patients with primary thrombocythemia].
    Jirát S; Stanĕk F; Jonásová A; Krivánek J; Tesar D
    Vnitr Lek; 1997 Oct; 43(10):672-7. PubMed ID: 9601882
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prevention of limb amputation in patients with limbs ulcers by autologous peripheral blood mononuclear cell implantation.
    Kawamura A; Horie T; Tsuda I; Ikeda A; Egawa H; Imamura E; Iida J; Sakata H; Tamaki T; Kukita K; Meguro J; Yonekawa M; Kasai M
    Ther Apher Dial; 2005 Feb; 9(1):59-63. PubMed ID: 15828908
    [TBL] [Abstract][Full Text] [Related]  

  • 64. An evidence-based model comparing the cost-effectiveness of platelet-rich plasma gel to alternative therapies for patients with nonhealing diabetic foot ulcers.
    Dougherty EJ
    Adv Skin Wound Care; 2008 Dec; 21(12):568-75. PubMed ID: 19065083
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Evaluation & management of lower extremity ulcers. Adherence to prescribed therapy can save limbs.
    Seaman S
    Adv Nurse Pract; 2002 Mar; 10(3):32-6, 39-42, 44 passim. PubMed ID: 12418335
    [No Abstract]   [Full Text] [Related]  

  • 66. Vascular assessment and reconstruction of the ischemic diabetic limb.
    Hagino RT
    Clin Podiatr Med Surg; 2007 Jul; 24(3):449-67, viii. PubMed ID: 17613385
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Therapeutic potential of stem cells in elderly patients with cardiovascular disease.
    Brehm M; Stanske B; Strauer BE
    Exp Gerontol; 2008 Nov; 43(11):1024-32. PubMed ID: 18845234
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Autologous mononuclear stem cell transplantation in patients with peripheral occlusive arterial disease.
    Bartsch T; Brehm M; Zeus T; Strauer BE
    J Cardiovasc Nurs; 2006; 21(6):430-2. PubMed ID: 17293730
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [New options for therapeutic revascularization in lower extremity limb ischemia linked to the diabetic foot syndrome by autologous stem cell transplantation].
    Svěcený J; Syková E; Tichý M; Laštůvka J
    Cas Lek Cesk; 2015; 154(4):161-7. PubMed ID: 26357857
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Meta-analysis on the treatment of diabetic foot ulcers with autologous stem cells.
    Guo J; Dardik A; Fang K; Huang R; Gu Y
    Stem Cell Res Ther; 2017 Oct; 8(1):228. PubMed ID: 29037219
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Treatment with autologous bone marrow mononuclear cells in patients with critical lower limb ischaemia. A pilot study.
    Wester T; Jørgensen JJ; Stranden E; Sandbaek G; Tjønnfjord G; Bay D; Kollerøs D; Kroese AJ; Brinchmann JE
    Scand J Surg; 2008; 97(1):56-62. PubMed ID: 18450207
    [TBL] [Abstract][Full Text] [Related]  

  • 72. New insights into the treatment of non-healing diabetic foot ulcers.
    Vicenti G; Bizzoca D; Caruso I; Nappi VS; Giancaspro G; Carrozzo M; Moretti B
    J Biol Regul Homeost Agents; 2018; 32(6 Suppl. 1):15-21. PubMed ID: 30644276
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Efficacy and long-term longitudinal follow-up of bone marrow mesenchymal cell transplantation therapy in a diabetic patient with recurrent lower limb bullosis diabeticorum.
    Chen Y; Ma Y; Li N; Wang H; Chen B; Liang Z; Ren R; Lu D; Boey J; Armstrong DG; Deng W
    Stem Cell Res Ther; 2018 Apr; 9(1):99. PubMed ID: 29631615
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clinical assessment of peripheral arterial occlusive risk factors in the diabetic foot.
    Helfand AE
    Int J Clin Pract; 2007 Apr; 61(4):540-1. PubMed ID: 17394426
    [No Abstract]   [Full Text] [Related]  

  • 75. Detailed protocol of ischemia and the use of noninvasive vascular laboratory testing in diabetic foot ulcers.
    Teodorescu VJ; Chen C; Morrissey N; Faries PL; Marin ML; Hollier LH
    Am J Surg; 2004 May; 187(5A):75S-80S. PubMed ID: 15147996
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Autologous stem cell-based therapy for sickle cell leg ulcer: a pilot study.
    Meneses JV; Fortuna V; de Souza ES; Daltro GC; Meyer R; Minniti CP; Borojevic R
    Br J Haematol; 2016 Dec; 175(5):949-955. PubMed ID: 27604498
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Polydeoxyribonucleotide (PDRN): a safe approach to induce therapeutic angiogenesis in peripheral artery occlusive disease and in diabetic foot ulcers.
    Altavilla D; Bitto A; Polito F; Marini H; Minutoli L; Di Stefano V; Irrera N; Cattarini G; Squadrito F
    Cardiovasc Hematol Agents Med Chem; 2009 Oct; 7(4):313-21. PubMed ID: 19860658
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Progress in stem cell therapy for the diabetic foot.
    Jiang XY; Lu DB; Chen B
    Diabetes Res Clin Pract; 2012 Jul; 97(1):43-50. PubMed ID: 22221581
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Stem cell use in critical limb ischemia.
    Kolvenbach R; Kreissig C; Ludwig E; Cagiannos C
    J Cardiovasc Surg (Torino); 2007 Feb; 48(1):39-44. PubMed ID: 17308520
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Foot mycoses in patients with arterial ischemia of the lower limbs].
    Macura AB; Mrówka T
    Med Dosw Mikrobiol; 1983; 35(1):49-54. PubMed ID: 6633033
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.